Fatigue is a major symptom in people with multiple sclerosis (MS), for which treatments are limited. Several studies have shown that a large proportion of men with MS have low testosterone levels. We propose a two-site clinical trial using topical testosterone gel as a treatment for MS-related fatigue in men with progressive MS who have low or low-normal testosterone levels.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
testosterone gel
Placebo gel
University of California, Los Angeles
Los Angeles, California, United States
Washington University
St Louis, Missouri, United States
Modified Fatigue Impact Scale (MFIS)
assessment of fatigue severity
Time frame: 18 months
Localized Gray Matter Atrophy
Quantify effect of testosterone treatment on localized gray matter atrophy
Time frame: 18 months
Axon Density in White Matter
Quantify effect of testosterone treatment on axon density in major white matter tracts
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.